Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroconvulsive Therapy for Refractory Fibromyalgia
NCT07835516Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2026
- Primary completion
- Feb 2028
01
Overview
Randomised, open-label trial in fibromyalgia (FM) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change in Average Pain Intensity at 1 month. Planned start Dec 2026; status: not yet recruiting.
02
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07835516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07835516.